Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
QuintilesIMS
Cipla
Boehringer Ingelheim
Merck
Dow
Medtronic
Accenture
Fuji
US Department of Justice

Generated: January 24, 2018

DrugPatentWatch Database Preview

ULTRAGRIS-165 Drug Profile

« Back to Dashboard

Which patents cover Ultragris-165, and when can generic versions of Ultragris-165 launch?

Ultragris-165 is a drug marketed by Pliva and is included in one NDA.

The generic ingredient in ULTRAGRIS-165 is griseofulvin, ultramicrocrystalline. There is one drug master file entry for this compound. Additional details are available on the griseofulvin, ultramicrocrystalline profile page.
Summary for ULTRAGRIS-165
Drug patent expirations by year for ULTRAGRIS-165

US Patents and Regulatory Information for ULTRAGRIS-165

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pliva ULTRAGRIS-165 griseofulvin, ultramicrocrystalline TABLET;ORAL 062645-001 Jun 30, 1992 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Chubb
Federal Trade Commission
Baxter
Dow
McKesson
QuintilesIMS
Colorcon
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot